Sponsor pipeline

Cumberland Pharmaceuticals clinical trial pipeline

Get alerts when Cumberland Pharmaceuticals's trials change

2 active trials 1 recruiting 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05571059 Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis Recruiting 2026-03-05
NCT02682511 Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated… Scleroderma, Diffuse Active, Not Recruiting 2026-04-15

Disease areas by active trials

Scleroderma (1) · Idiopathic Pulmonary Fibrosis (1)

Get alerts when Cumberland Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free